FI951298A - 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus - Google Patents

2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus Download PDF

Info

Publication number
FI951298A
FI951298A FI951298A FI951298A FI951298A FI 951298 A FI951298 A FI 951298A FI 951298 A FI951298 A FI 951298A FI 951298 A FI951298 A FI 951298A FI 951298 A FI951298 A FI 951298A
Authority
FI
Finland
Prior art keywords
kynurenine
phenyl
amino
kynureninase
acid derivatives
Prior art date
Application number
FI951298A
Other languages
English (en)
Swedish (sv)
Other versions
FI951298A0 (fi
Inventor
Mario Varasi
Antonio Giordani
Carmela Speciale
Massino Cini
Alberto Bianchetti
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of FI951298A0 publication Critical patent/FI951298A0/fi
Publication of FI951298A publication Critical patent/FI951298A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
FI951298A 1993-07-23 1995-03-20 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus FI951298A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001649A IT1265101B1 (it) 1993-07-23 1993-07-23 Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
PCT/EP1994/002280 WO1995003271A1 (en) 1993-07-23 1994-07-12 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity

Publications (2)

Publication Number Publication Date
FI951298A0 FI951298A0 (fi) 1995-03-20
FI951298A true FI951298A (fi) 1995-03-20

Family

ID=11366678

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951298A FI951298A (fi) 1993-07-23 1995-03-20 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus

Country Status (21)

Country Link
US (1) US20010008947A1 (fi)
EP (1) EP0662948B1 (fi)
JP (1) JPH08501805A (fi)
KR (1) KR950703517A (fi)
CN (1) CN1112786A (fi)
AT (1) ATE171935T1 (fi)
AU (1) AU678273B2 (fi)
CA (1) CA2144521A1 (fi)
DE (1) DE69413789T2 (fi)
DK (1) DK0662948T3 (fi)
ES (1) ES2123801T3 (fi)
FI (1) FI951298A (fi)
HU (1) HUT70478A (fi)
IL (1) IL110365A (fi)
IT (1) IT1265101B1 (fi)
NZ (1) NZ268896A (fi)
PL (1) PL179857B1 (fi)
RU (1) RU2139850C1 (fi)
TW (1) TW268937B (fi)
WO (1) WO1995003271A1 (fi)
ZA (1) ZA945425B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519055A (en) * 1993-08-06 1996-05-21 University Of Maryland At Baltimore Substituted kynurenines and process for their preparation
US5786508A (en) * 1994-07-15 1998-07-28 Pharmacia & Upjohn S.P.A. Substituted kynurenines and process for their preparation
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
GB9615441D0 (en) * 1996-07-23 1996-09-04 Pharmacia Spa Benzoylpropionic acid ester derivatives
EP0923569B1 (en) * 1996-08-16 2004-11-17 Warner-Lambert Company Llc Butyric acid matrix metalloproteinase inhibitors
GB9618349D0 (en) * 1996-09-03 1996-10-16 Pharmacia Spa N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
GB9716103D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
GB9725055D0 (en) * 1997-11-26 1998-01-28 Pharmacia & Upjohn Spa 1,3,4-thiadiazoles compounds
GB9725141D0 (en) * 1997-11-27 1998-01-28 Pharmacia & Upjohn Spa Benzenesulfonamide compounds
DE69932414T2 (de) * 1998-02-23 2007-02-22 South Alabama Medical Science Foundation, Mobile Indol-3-propionsäure, salze und ester davon als arzneimittel #
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
JP4503184B2 (ja) * 1998-11-11 2010-07-14 ノヴァルティス アーゲー 2−アミノ−2−[2−(4−c2−20−アルキル−フェニル)エチル]プロパン−1,3−ジオール類の製造
CN1144779C (zh) * 1999-03-11 2004-04-07 杭州中美华东制药有限公司 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物
KR100959356B1 (ko) * 2001-06-12 2010-05-20 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
FR2827859B1 (fr) 2001-07-30 2005-09-23 Lipha Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete
CN1330774C (zh) * 2002-03-01 2007-08-08 国家人类基因组南方研究中心 犬尿氨酸水解酶多态性及其用途
ITMI20041626A1 (it) * 2004-08-06 2004-11-06 Roberto Pellicciari Inibitori della chinurenina-ammino-trasferasi
CN1309702C (zh) * 2005-10-28 2007-04-11 中国科学院上海有机化学研究所 犬尿氨酸酶的特异性抑制剂l-邻甲氧基苯甲酰基丙氨酸的合成方法
JP5698118B2 (ja) * 2008-03-19 2015-04-08 ノバルティス アーゲー 2−アミノ−2−[2−(4−c3〜c21−アルキル−フェニル)エチル]プロパン−1,3−ジオールの調製方法
PL3197466T3 (pl) * 2014-09-26 2021-09-13 The University Of British Columbia Kombinacja kinureniny i komórek prezentujących antygen (antigen presenting cells, apc) jako środków terapeutycznych i sposoby ich stosowania w modulacji układu odpornościowego

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0624569T3 (da) * 1991-02-28 1998-10-26 Merrell Pharma Inc MMDA-antagonister
US5495044A (en) * 1991-04-18 1996-02-27 University Of Georgia Research Foundation, Inc. Inhibitors of kynureninase
CA2108670A1 (en) * 1991-04-18 1992-10-19 Robert S. Phillips Inhibitors of kynureninase
GB9325360D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds

Also Published As

Publication number Publication date
HU9501146D0 (en) 1995-06-28
RU2139850C1 (ru) 1999-10-20
IL110365A0 (en) 1994-10-21
PL308142A1 (en) 1995-07-24
DK0662948T3 (da) 1999-06-21
AU7228594A (en) 1995-02-20
ITMI931649A0 (it) 1993-07-23
EP0662948B1 (en) 1998-10-07
DE69413789D1 (de) 1998-11-12
JPH08501805A (ja) 1996-02-27
EP0662948A1 (en) 1995-07-19
IL110365A (en) 1998-06-15
IT1265101B1 (it) 1996-10-30
AU678273B2 (en) 1997-05-22
ITMI931649A1 (it) 1995-01-23
CA2144521A1 (en) 1995-02-02
PL179857B1 (pl) 2000-11-30
US20010008947A1 (en) 2001-07-19
KR950703517A (ko) 1995-09-20
ZA945425B (en) 1995-03-01
HUT70478A (en) 1995-10-30
FI951298A0 (fi) 1995-03-20
CN1112786A (zh) 1995-11-29
NZ268896A (en) 1997-01-29
DE69413789T2 (de) 1999-05-06
WO1995003271A1 (en) 1995-02-02
ES2123801T3 (es) 1999-01-16
TW268937B (fi) 1996-01-21
RU95111308A (ru) 1996-12-27
ATE171935T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
FI951298A0 (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
DE69429527D1 (de) Inhibitoren von beta-amyloid-protein-herstellung
BG101841A (en) Cellular adhesion inhibitors
EP1449834A3 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
ES2145913T3 (es) Inhibidores de metaloproteasas.
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DK0705100T3 (da) Terapeutiske substituerede guanidiner
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
SE9604348D0 (sv) Användning av hydroxyguanidiner
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
AU5857899A (en) Use of tgf-beta inhibitors for treating cerebral disorders
EA199800546A1 (ru) Производные тиола, обладающие (ace/nep) ингибирующим действием на металлопептидазу
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.